메니에르병에서 고실 내 스테로이드 주입술에 대한 고찰

키워드

참고문헌 (56)

1. Alexander TH, "Current epidemiology of Meniere’s syndrome", Otolaryngol Clin North Am, 43(5), pp.965~970 (2010)
2. Shojaku H, "Epidemiologic characteristics of definite Ménière's disease in Japan. A long-term survey of Toyama and Niigata prefectures", ORL J Otorhinolaryngol Relat Spec, 67(5), pp.305~309 (2005)
3. Kim MH, "Epidemiology and seasonal variation of Ménière’s disease : data from a population-based study", Audiol Neurotol, 25(4), pp.224~230 (2020)
4. Lopez-Escamez JA, "Diagnostic criteria for Ménière’s disease", J Vestib Res, 25(1), pp.1~7 (2015)
5. Sajjadi H, "Meniere’s disease", Lancet, 372(9636), pp.406~414 (2008)
6. Basura GJ, "Clinical practice guideline : ménière’s disease", Otolaryngol Head Neck Surg, 162(2 Suppl), pp.S1~55 (2020)
7. Magnan J, "European position statement on diagnosis, and treatment of Ménière’s disease", J Int Adv Otol, 14(2), pp.317~321 (2018)
8. Albu S, "Intratympanic dexamethasone versus high dosage of betahistine in the treatment of intractable unilateral Ménière’s disease", Am J Otolaryngol, 36(2), pp.205~209 (2015)
9. Paragache G, "Intratympanic dexamethasone application in Ménière's disease: is it superior to conventional therapy?", Indian J Otolaryngol Head Neck Surg, 57, pp.21~23 (2005)
10. Itoh A, "Treatment of vestibular disorders", Acta Otolaryngol, 111(sup481), pp.617~623 (1991)
11. Plontke SK, "Cochlear pharmacokinetics with local inner ear drug delivery using a three-dimensional finite-element computer model", Audiol Neurotol, 12(1), pp.37~48 (2007)
12. Sun JJ, "In vitro permeability of round window membrane to transforming dexamethasone with delivery vehicles : a dosage estimation", Chin Med J, 120(24), pp.2284~2289 (2007)
13. Ghaheri BA, "Cochlear cytokine gene expression in murine chronic otitis media", Otolaryngol Head Neck Surg, 137(2), pp.332~337 (2007)
14. Diao M, "Nitric oxide synthase inhibitor reduces noise-induced cochlear damage in guinea pigs", Acta Otolaryngol, 127(11), pp.1162~1167 (2007)
15. Tabuchi K, "Protective effects of glucocorticoids on ischemia–reperfusion injury of outer hair cells", Laryngoscope, 116(4), pp.627~629 (2006)
16. Hamid M, "Issues, indications, and controversies regarding intratympanic steroid perfusion", Curr Opin Otolaryngol Head Neck Surg, 16, pp.434~440 (2008)
17. Fukushima M, "Effects of intratympanic injection of steroids on changes in rat inner ear aquaporin expression", Acta Otolaryngol, 122, pp.600~606 (2002)
18. Trune DR, "Glucocorticoid impact on cochlear function and systemic side effects in autoimmune C3.MRL-Faslpr and normal C3H", HeJ mice, 2007, pp.226(1–2), 209~217
19. Gabashvili IS, "Ion channel gene expression in the inner ear", J Assoc Res Otolaryngol, 8(3), pp.305~328 (2007)
20. Sakata E, "Treatment of Ménière's disease. Middle ear infusion with lidocaine and steroid solution", Auris Nasus Larynx, 13(2), pp.79~89 (1986)
21. Parnes LS, "Corticosteroid pharmacokinetics in the inner ear fluids : an animal study followed by clinical application", Laryngoscope, 109(S91), pp.1~17 (1999)
22. Bird PA, "Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph", Otol Neurotol, 32(6), pp.933~936 (2011)
23. Bird PA, "Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph", Otol Neurotol, 28(8), pp.1124~1130 (2007)
24. Alles MJRC, "Intratympanic steroid therapy for inner ear diseases, a review of the literature", Eur Arch Otorhinolaryngol, 263(9), pp.791~797 (2006)
25. Phillips JS, "Intratympanic steroids for Ménière’s disease or syndrome", Cochrane Database Syst Rev, 008514~ (2011)
26. Pradhan P, "Long term outcomes of intratympanic dexamethasone in intractable unilateral Ménière’s disease", Indian J Otolaryngol Head Neck Surg, 71(2), pp.1369~1373 (2019)
27. Molnár A, "Effectiveness of intratympanic dexamethasone for the treatment of vertigo attacks in patients with Ménière’s disease compared with betahistine pharmacotherapy", J Int Med Res, 49(4), pp.0300060520985647~ (2021)
28. Pullens B, "Intratympanic gentamicin for Ménière’s disease or syndrome", Cochrane Database Syst Rev, pp.CD008234~ (2011)
29. Casani AP, "Intratympanic treatment of intractable unilateral Ménière’s disease : gentamicin or dexamethasone? A randomized controlled trial", Otolaryngol Head Neck Surg, 146(3), pp.430~437 (2012)
30. Patel M, "Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière’s disease : a randomised, double-blind, comparative effectiveness trial", Lancet, 388(10061), pp.2753~2762 (2016)
31. Hao W, "Effects of intratympanic gentamicin and intratympanic glucocorticoids in Ménière's disease : a network meta-analysis", J Neurol, pp.1~15 (2021)
32. Cao Z, "Different medications for the treatment of Ménière’s disease by intratympanic injection : a systematic review and network meta-analysis", Clin Otolaryngol, 44(4), pp.619~627 (2019)
33. Huppert D, "Long-term course of Ménière’s disease revisited", Acta Otolaryngol, 130(6), pp.644~651 (2010)
34. Harcourt JP, "Long-term follow-up of intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière’s disease", Otol Neurotol, 40(4), pp.491~496 (2019)
35. Salt AN, "Steroid nomenclature in inner ear therapy", Otol Neurotol, 41, pp.722~726 (2020)
36. Battaglia A, "Combination therapy(intratympanic dexamethasone + high-dose prednisone taper)for the treatment of idiopathic sudden sensorineural hearing loss", Otol Neurotol, 29(4), pp.453~460 (2008)
37. Salt AN, "Comparison of the pharmacokinetic properties of triamcinolone and dexamethasone for local therapy of the inner ear", Front Cell Neurosci, 13, pp.347~ (2019)
38. Gabra N, "The effect of intratympanic methylprednisolone and gentamicin injection on Ménière’s disease", Otolaryngol Head Neck Surg, 148(4), pp.642~647 (2013)
39. Garduño-Anaya MA, "Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière’s disease : a two-year prospective, placebo-controlled, double-blind, randomized trial", Otolaryngol Head Neck Surg, 133(2), pp.285~294 (2005)
40. Memari F, "Effect of intratympanic dexamethasone on controlling tinnitus and hearing loss in Ménière’s disease", Iran J Otorhinolaryngol, 26(76), pp.129~133 (2014)
41. Jumaily M, "Intratympanic triamcinolone and dexamethasone in the treatment of Ménière’s syndrome", Otol Neurotol, 38(3), pp.386~391 (2017)
42. She W, "Long-term effects of intratympanic methylprednisolone perfusion treatment on intractable Ménière's disease", J Laryngol Otol, 129(3), pp.232~237 (2015)
43. Masoumi E, "Methylprednisolone versus dexamethasone for control of vertigo in patients with definite Ménière’s disease : a randomized clinical trial", Iran J Otorhinolaryngol, 29(6), pp.341~346 (2017)
44. Hobson CE, "Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexamethasone", Curr Opin Otolaryngol Head Neck Surg, 24, pp.407~412 (2016)
45. Engleder E, "Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear", Int J Pharm, 471(1-2), pp.297~302 (2014)
46. Kuppermann BD, "Steroid differentiation:the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis)", Trans Am Ophthalmol Soc, 112, pp.116~141 (2014)
47. Plontke SK, "Dexamethasone concentration gradients along scala tympani after application to the round window membrane", Otol Neurotol, 29(3), pp.401~406 (2008)
48. Beyea JA, "Intratympanic dexamethasone in the treatment of Ménière's disease : a comparison of two techniques", Otol Neurotol, 38(6), pp.e173~8 (2017)
49. Leng Y, "Repeated courses of intratympanic dexamethasone injection are effective for intractable Ménière’s disease", Acta Otolaryngol, 137(2), pp.154~160 (2017)
50. Topf MC, "Rate of tympanic membrane perforation after intratympanic steroid injection", Am J Otolaryngol, 38(1), pp.21~25 (2017)
51. Kim YH, "Tympanic membrane perforation after intratympanic steroid injection : a systematic review and meta-analysis", Otolaryngol Head Neck Surg, pp.01945998211012300~ (2021)
52. Liu YC, "Assessment of complications due to intratympanic injections", World J Otorhinolaryngol Head Neck Surg, 2(1), pp.13~16 (2016)
53. Rutt AL, "Incidence of tympanic membrane perforation after intratympanic steroid treatment through myringotomy tubes", Ear Nose Throat J, 90(4), pp.E21~7 (2011)
54. Yu YF, "The role of caloric testing and the vestibular evoked myogenic potential in the efficacy of intratympanic dexamethasone injection in 201 patients with unilateral Ménière's disease", Clin Otolaryngol, 45(4), pp.634~642 (2020)
55. Shea JJ Jr, "The role of dexamethasone or streptomycin perfusion in the treatment of Ménière’s disease", Otolaryngol Clin North Am, 30(6), pp.1051~1059 (1997)
56. Silverstein H, "Dexamethasone inner ear perfusion for the treatment of Ménière’s disease : a prospective, randomized, double-blind, crossover trial", Am J Otol, 19(2), pp.196~201 (1998)

관련 논문AI추천